Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 174
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04959799 | Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA) | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | ||
| NCT05817669 | A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) | ||
| NCT03566082 | Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe | ||
| NCT06504446 | Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough | ||
| NCT07712484 | A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC | ||
| NCT06559891 | THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension | ||
| NCT05186324 | Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion | ||
| NCT02654470 | Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only) | ||
| NCT04376554 | Effect of Tebipenem on Normal Human Intestinal Microbiota | ||
| NCT05925595 | Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis | ||
| NCT04201132 | Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System | ||
| NCT04025307 | Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours | ||
| NCT05731908 | A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | ||
| NCT04206917 | MultiPulse Therapy (MPT) for AF | ||
| NCT05243680 | An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) | ||
| NCT03193476 | Registry for Patients With X-Linked Hypophosphatemia | ||
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | ||
| NCT06203457 | Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome | ||
| NCT06042049 | A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab | ||
| NCT04247581 | ECG App Algorithms Clinical Validation Study | ||
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | ||
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | ||
| NCT04980638 | Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia | ||
| NCT05835349 | Observational Study of Venus P-Valve | ||
| NCT06951867 | Tezspire Cardiac Events PASS | ||
| NCT05551195 | [Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression] | ||
| NCT03721263 | Study of ASLAN004 in Healthy Subjects | ||
| NCT06485674 | Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus | ||
| NCT05761444 | Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients | ||
| NCT03838185 | Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 | ||
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT04125290 | US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) | ||
| NCT03994328 | An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD | ||
| NCT02104817 | Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia | ||
| NCT04814680 | Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate | ||
| NCT04396340 | First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b | ||
| NCT03369262 | PoC Study of OBE022 in Threatened Preterm Labour | ||
| NCT06712563 | Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT04167137 | Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants | ||
| NCT05663515 | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs | ||
| NCT03447314 | Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors | ||
| NCT04641481 | An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers | ||
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | ||
| NCT04027439 | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler | ||
| NCT02953652 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT03077477 | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers |
